Takeda and GSK Challenge Latest Data Linking TZDs To Cardiovascular Events

Takeda and GlaxoSmithKline are disputing the findings of a Canadian study published in the December 12 issue of the Journal of the American Medical Association linking thiazolidinediones to cardiovascular events